腾盛博药-B
港股通 官网
( 02137.hk)
市盈率-2.97市净率0.28股息率0%上市时间2021-07-13股价1.00港币涨跌幅3.09%成交金额7.88万港币换手率0.01%市值7.35亿港币H股市值7.35亿港币总股本7.35亿H股本7.35亿每手股数500上市至今年化投资收益率-46.29%港股通持仓占H股比例19.15% (1.41亿港币2026-07-22)
所属三级行业生物技术 (恒生) 市盈率122.29市净率4.46股息率0.37%恒生:医疗保健业药品及生物科技生物技术
备注 (6): 双击编辑备注
发表讨论

腾盛博药-B(02137) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1李安康Executive Director2022-09-30--
2楊台瑩Independent Non Executive Director2022-09-01--
3ALTON Gregg HuberIndependent Non Executive Director2021-07-13--
4MURPHY Martin JIndependent Non Executive Director2021-07-13--
5TANG Hui GraceIndependent Non Executive Director - A/F2021-07-13--
6徐耀華Independent Non Executive Director2021-07-13--
7BOUCHON AxelNon Executive Director2021-06-222022-09-30
8羅永慶Executive Director2021-03-302022-09-15
9NELSEN Robert TaylorNon Executive Director2018-06-22--
10HONG ZhiExecutive DirectorChairman, CEO2018-03-02--